David Olmos

19.4k total citations · 3 hit papers
233 papers, 10.4k citations indexed

About

David Olmos is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, David Olmos has authored 233 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Pulmonary and Respiratory Medicine, 100 papers in Oncology and 85 papers in Cancer Research. Recurrent topics in David Olmos's work include Prostate Cancer Treatment and Research (135 papers), Radiopharmaceutical Chemistry and Applications (48 papers) and PARP inhibition in cancer therapy (46 papers). David Olmos is often cited by papers focused on Prostate Cancer Treatment and Research (135 papers), Radiopharmaceutical Chemistry and Applications (48 papers) and PARP inhibition in cancer therapy (46 papers). David Olmos collaborates with scholars based in United Kingdom, Spain and United States. David Olmos's co-authors include Johann S. de Bono, Shahneen Sandhu, Fred Saad, Joaquı́n Mateo, Gerhardt Attard, Kim N., Karim Fizazi, Neeraj Agarwal, Carrie A. Adelman and Antoine Thiery-Vuillemin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David Olmos

224 papers receiving 10.3k citations

Hit Papers

Olaparib for Metastatic Castration-Resistant Prostate Cancer 2018 2026 2020 2023 2020 2018 2020 400 800 1.2k

Peers

David Olmos
Comparison fields: 5 of 139
  • Pulmonary and Respiratory Medicine 6.3k
  • Oncology 4.1k
  • Molecular Biology 3.2k
  • Cancer Research 3.2k
  • Radiology, Nuclear Medicine and Imaging 1.4k
Replace Neeraj Agarwal with:
Neeraj Agarwal United States
Paul N. Mainwaring Australia
Glenn Liu United States
Mustafa Özgüroğlu Türkiye
Eleni Efstathiou United States
Vivek Subbiah United States
Christophe Massard France
David M. Nanus United States
A Płużańska Poland
Hidefumi Sasaki Japan
Neeraj Agarwal United States View profile →
Citations per field, relative to David Olmos
David Olmos · 1×
Citations per year, relative to David Olmos
David Olmos · 1×

Countries citing papers authored by David Olmos

Since Specialization
Citations

This map shows the geographic impact of David Olmos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Olmos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Olmos more than expected).

Fields of papers citing papers by David Olmos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Olmos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Olmos. The network helps show where David Olmos may publish in the future.

Co-authorship network of co-authors of David Olmos

This figure shows the co-authorship network connecting the top 25 collaborators of David Olmos. A scholar is included among the top collaborators of David Olmos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Olmos. David Olmos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 5
2 4
3 2
4 2
5 5
6 6
7 46
8 9
9
Olaparib for Metastatic Castration-Resistant Prostate Cancer breakdown →
1397
10
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer breakdown →
474
11 17
12 294
13 14
14 60
15 41
16 50
17 134
18 21
19
An analysis of the risk of toxicity associated with participation in phase 1 oncology trials of novel molecularly targeted agents (mta) at the drug development unit, royal marsden hospital
5
20 134

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026